据最新消息，迈富时（02556.HK）宣布与创新药企银诺医药（02591.HK）正式达成战略合作，双方将围绕AI智能体技术在患者服务、市场推广、专业交互及产业方案等关键场景的落地展开深度协作，探索医药健康价值链中的AI创新解决方案，共同推动医药健康产业迈入高质量、智能化的发展新阶段。作为中国最大的营销及销售AI SaaS企业，迈富时在AI Agent技术领域持续深耕，持续拓展AI Agent在垂直...
Source Link据最新消息，迈富时（02556.HK）宣布与创新药企银诺医药（02591.HK）正式达成战略合作，双方将围绕AI智能体技术在患者服务、市场推广、专业交互及产业方案等关键场景的落地展开深度协作，探索医药健康价值链中的AI创新解决方案，共同推动医药健康产业迈入高质量、智能化的发展新阶段。作为中国最大的营销及销售AI SaaS企业，迈富时在AI Agent技术领域持续深耕，持续拓展AI Agent在垂直...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.